Send the following on WhatsApp
Continue to Chathttps://nl.marketscreener.com/koers/aandeel/ARGENX-SE-16911676/nieuws/Argenx-Se-zet-de-klinische-ontwikkeling-van-efgartigimod-bij-de-ziekte-van-Sjogren-voort-46301578/?utm_source=whatsapp&utm_medium=social&utm_campaign=share